Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner

Carcinogenesis

Volumn 33, Issue 12, 2012, Pages 2538-2547

  Singh, Amar B ^a   Sharma, Ashok ^a   Dhawan, Punita ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE P60; PROTEIN ZO1;

ANOIKIS; ARTICLE; CANCER CELL; COLON CARCINOGENESIS; COLORECTAL CANCER; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TUMOR GROWTH; UPREGULATION;

ANOIKIS; CELL LINE, TUMOR; CLAUDIN-1; COLONIC NEOPLASMS; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SRC-FAMILY KINASES;

EID: 84870355576     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs275     Document Type: Article

References (51)

1. Guadamillas, M.C. et a.l (2011) Overcoming anoikis-pathways to anchorage-independent growth in cancer. J. Cell Sci., 124, 3189-3197.
2. Rosen, K. et al. (2000) Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J. Cell Biol., 149, 447-456.
3. Duxbury, M.S. et al. (2004) EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene, 23, 1448-1456.
4. Yoo, B.H. et al (2012) Tumor suppressor protein kinase Chk2 is a mediator of anoikis of intestinal epithelial cells. Int. J. Cancer, 131, 357-366.
5. Dhawan, P. et al. (2005) Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J. Clin. Invest., 115, 1765-1776.
6. Dos Reis, P.P. et al. (2008) Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma. Cancer, 113, 3169-3180.
7. Lee, J.W. et al. (2005) Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol. Oncol., 97, 53-59.
8. Chen, J. (2008) Is Src the key to understanding metastasis and developing new treatments for colon cancer? Nat. Clin. Pract. Gastroenterol. Hepatol., 5, 306-307.
9. Zhao, J. et al. (2009) Migfilin interacts with Src and contributes to cellmatrix adhesion-mediated survival signaling. J. Biol. Chem., 284, 34308-34320.
10. Avizienyte, E. et al. (2002) Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat. Cell Biol., 4, 632-638.
11. Windham, C. et al (2002) Src activation regulates anoikis in human colon tumor cell lines. Oncogene, 21, 7797-7807.
12. Demers, M.J. et al. (2009) Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1. J. Cell. Biochem., 107, 639-654.
13. Bouchard, V. et al. (2008) B1 integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms. Apoptosis, 13, 531-542.
14. Harada, K. et al. (2011) Ephexin4 and EphA2 mediate resistance to anoikis through RhoG and phosphatidylinositol 3-kinase. Exp. Cell Res., 317, 1701-1713.
15. Nagaprashantha, L.D. et al. (2011) The sensors and regulators of cellmatrix surveillance in anoikis resistance of tumors. Int. J. Cancer, 128, 743-752.
16. Wei, L. et al. (2004) Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene, 23, 9052-9061.
17. Reginato, M.J. et al. (2005) Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol. Cell. Biol., 25, 4591-4601.
18. Yamaguchi, H. et al. (2008) SRC directly phosphorylates Bif-1 and prevents its interaction with Bax and the initiation of anoikis. J. Biol. Chem., 283, 19112-19118.
19. Zouq, N.K. et al. (2009) FAK engages multiple pathways to maintain survival of fibroblasts and epithelia: differential roles for paxillin and p130Cas. J. Cell. Sci., 122(Pt 3), 357-367.
20. Sachdev, S. et al. (2009) Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion. BMC Cancer, 9, 12.
21. Manuel, G.C. et al. (2006) PI3K and ERK 1-2 regulate early stages during head regeneration in hydra. Dev. Growth Differ., 48, 129-138.
22. Lei, J. et al. (2011) Src kinase integrates PI3K/Akt and MAPK/ERK1/2 pathways in T3-induced Na-K-ATPase activity in adult rat alveolar cells. Am. J. Physiol. Lung Cell Mol. Physiol., 301, L765-L771.
23. Haenssen, K.K. et al (2010) ErbB2 requires integrin α5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. J. Cell Sci., 123, 1373-1382.
24. Gilleron, J. et al. (2009) Connexin 43 gap junction plaque endocytosis implies molecular remodelling of ZO-1 and c-Src partners. Commun. Integr. Biol., 2, 104-106.
25. Nomme, J. et al. (2011) The Src homology 3 domain is required for junctional adhesion molecule binding to the third PDZ domain of the scaffolding protein ZO-1. J. Biol. Chem., 286, 43352-43360.
26. Itoh, M. et al. (1999) Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J. Cell Biol., 147, 1351-1363.
27. Mayo, S.C. et al. (2009) Current management of colorectal hepatic metastasis. Expert Rev. Gastroenterol. Hepatol., 3, 131-144.
28. Leotlela, P.D. et al. (2007) Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene, 26, 3846-3856.
29. Windham, T.C. et al. (2002) Src activation regulates anoikis in human colon tumor cell lines. Oncogene, 21, 7797-7807.
30. González-Mariscal, L. et al. (2003) Tight junction proteins. Prog. Biophys. Mol. Biol., 81, 1-44.
31. Coll, M.L. et al. (2002) Increased Bcl-xL expression mediates v-Srcinduced resistance to anoikis in intestinal epithelial cells. Oncogene, 21, 2908-2913.
32. Galante, J.M. et al. (2009) ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis. J. Surg. Res., 152, 18-25.
33. Youle, R.J. et al. (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol., 9, 47-59.
34. Beauséjour, M. et al. (2012) Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes. Apoptosis, 17, 566-578.
35. Mahajan, K. et al. (2012) PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics. J. Cell. Physiol., 227, 3178-3184.
36. Singh, A.B. et al. (2011) Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. Gastroenterology, 141, 2140-2153.
37. Wilmanns, C. et al. (2012) Cooperate concept of metastasis: site-specific requirement of activated differentiation and dynamic deterioration. Cancer Metastasis Rev., 31, 269-276.
38. Baranwal, S. et al. (2009) Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem. Biophys. Res. Commun., 384, 6-11.
39. Wells, A. et al. (2008) E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin. Exp. Metastasis, 25, 621-628.
40. Hikita, T. et al. (2010) Purvalanol A, a CDK inhibitor, effectively suppresses Src-mediated transformation by inhibiting both CDKs and c-Src. Genes Cells, 15, 1051-1062.
41. Lioni, M. et al. (2007) Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am. J. Pathol., 170, 709-721.
42. Zeisel, M.B. et al. (2011) Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. J. Hepatol., 54, 566-576.
43. Ding, L. et al. (2012) Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice. Gastroenterology, 142, 305-315.
44. Mitra, S.K. et al. (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol., 18, 516-523.
45. Serrels, A. et al. (2011) Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging. Cell Adh. Migr., 5, 360-365.
46. Caccavari, F. et al. (2010) Integrin signaling and lung cancer. Cell Adh. Migr., 4, 124-129.
47. Tuomi, S. et al. (2009) PKCepsilon regulation of an alpha5 integrin-ZO-1 complex controls lamellae formation in migrating cancer cells. Sci. Signal., 2, ra32.
48. Meyer, T.N. et al. (2002) Zonula occludens-1 is a scaffolding protein for signaling molecules. Galpha(12) directly binds to the Src homology 3 domain and regulates paracellular permeability in epithelial cells. J. Biol. Chem., 277, 24855-24858.
49. Lie, P.P. et al. (2010) Crosstalk between desmoglein-2/desmocollin-2/Src kinase and coxsackie and adenovirus receptor/ZO-1 protein complexes, regulates blood-testis barrier dynamics. Int. J. Biochem. Cell Biol., 42, 975-986.
50. Nunbhakdi-Craig, V. et al. (2002) Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J. Cell Biol., 158, 967-978.
51. Van Itallie, C.M. et al. (2011) Claudin-2 forms homodimers and is a component of a high molecular weight protein complex. J. Biol. Chem., 286, 3442-3450.